References
- Fletcher CD. The evolving classification of soft tissue tumours: An update based on the new WHO classification. Histopathology 2006;48:3–12.
- Spitz FR, Bouvet M, Pisters PW, Pollock RE, Feig BW. Hemangiopericytoma: A 20-year single-institution experience. Ann Surg Oncol 1998;5:350–5.
- Espat NJ, Lewis JJ, Leung D, Woodruff JM, Antonescu CR, Shia J, . Conventional hemangiopericytoma: Modern analysis of outcome. Cancer 2002;95:1746–51.
- Galanis E, Buckner JC, Scheithauer BW, Kimmel DW, Schomberg PJ, Piepgras DG. Management of recurrent meningeal hemangiopericytoma. Cancer 1998;82:1915–20.
- Magdeleinat P, Alifano M, Petino A, Le Rochais JP, Dulmet E, Galateau F, . Solitary fibrous tumors of the pleura: Clinical characteristics, surgical treatment and outcome. Eur J Cardiothorac Surg 2002;21:1087–93.
- Wong PP, Yagoda A. Chemotherapy of malignant hemangiopericytoma. Cancer 1978;41:1256–60.
- Peixoto Callejo I. Peritoneal solitary fibrous tumour (SFT): Long-term survival of recurrent and metastasised SFT treated with cytoreductive surgery and intraperitoneal chemotherapy. Clin Transl Oncol 2009;11:250–2.
- Kozuka T, Kiura K, Katayama H, Fujii N, Ishimaru F, Ikeda K, . Tandem high-dose chemotherapy supported by autologous peripheral blood stem cell transplantation for recurrent soft tissue sarcoma. Anticancer Res 2002;22: 2939–44.
- Jones RL, Olmos D, Thway K, Fisher C, Tunariu N, Postel-Vinay S, . Clinical benefit of early phase clinical trial participation for advanced sarcoma patients. Cancer Chemother Pharmacol 2011;68:423–9.
- Chamberlain MC, Glantz MJ. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery 2008;63:720–6; author reply 26–7.
- Lackner H, Urban C, Dornbusch HJ, Schwinger W, Kerbl R, Sovinz P. Interferon alfa-2a in recurrent metastatic hemangiopericytoma. Med Pediatr Oncol 2003;40:192–4.
- Kirn DH, Kramer A. Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma. J Natl Cancer Inst 1996;88:764–5.
- Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, . Combination therapy with temozolomide and bevacizumab in the treatment of hemangiopericytoma/ malignant solitary fibrous tumor [abstract]. J Clin Oncol 2008;26:10512.
- Ryan CW, von Mehren M, Rankin CJ, Goldblum JR, Demetri GD, Bramwell VH, . Phase II intergroup study of sorafenib in advanced soft tissue sarcomas: SWOG 0505 [abstract]. J Clin Oncol 2008;26:10532.
- Mulamalla K, Truskinovsky AM, Dudek AZ. Rare case of hemangiopericytoma responds to sunitinib. Transl Res 2008;151:129–33.
- Sleijfer S, Ray-Coquard I, Papai Z, Le Cesne A, Scurr M, Schoffski P, . Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: A phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009;27:3126–32.